LUNGevity Foundation presents career development awards
Click Here to Manage Email Alerts
LUNGevity Foundation announced the recipients of its career development awards for lung cancer research.
The recipients and their research projects are:
• Kathryn Arbour, MD, of Memorial Sloan Kettering Cancer Center — Mechanisms of resistance to direct KRAS G12C inhibition;
• Carl Gay, MD, PhD, of The University of Texas MD Anderson Cancer Center — Small cell lung cancer molecular subtypes to predict targeted and immune therapy response; and
• Sean Pitroda, MD, of The University of Chicago — Predictive biomarkers of radio-immunotherapeutic response in non-small cell lung cancer.
“By funding young investigators, LUNGevity keeps outstanding scientists, still early in their careers, in the lung cancer space. We work closely with these researchers with the hope of seeing them become the next generation of scientific superstars,” Upal Basu Roy, PhD, MPH, vice president of research at LUNGevity, said in a press release. “The career development awards program encourages their continued development in the field of lung cancer research to grow a strong pipeline of dedicated lung cancer researchers.”
The renewable awards provide $100,000 per year for up to 3 years. Award recipients are mentored by senior lung cancer experts at their own institutions, as well as by experts from the scientific advisory board of LUNGevity Foundation, a lung cancer-focused nonprofit organization.
Click Here to Manage Email Alerts